Articles
-
How COVID Can Help Us Refocus on the How and Why of Value Assessment
The limitations of conventional approaches to value assessment are particularly clear when reflecting on our experience with the COVID-19 pandemic.
Categorized in -
Economic Incentives for Administrative Simplification
In the US health care system, payers, health systems, physicians, other clinicians, drug companies, pharmacies, and pharmacy benefit managers all earn more revenue because of administrative complexity.
Categorized in -
Schaeffer Health Economist Elected to the National Academy of Medicine
Schaeffer Center Senior Fellow Paul Ginsburg’s contributions to health policy include pivotal improvements to Medicare and our understanding of insurance and provider markets.
-
Federal 340B Drug Pricing Policies Need Reform to Realize Potential
USC Schaeffer study finds Federal 340B Drug Pricing Program oversight needs tightening to ensure discounts reach the right safety-net providers and patients
Categorized in -
The Hidden Cost of Covid-19: Years of Life Lost Among the Young
The focus on deaths affecting mainly the elderly is unfortunate because it likely created a false sense of security among the young.
Categorized in -
Biosimilars Competition Helps Patients More Than Generic Competition
Well-intended proposals to have the government intervene and “incentivize” biosimilar uptake may result in less price competition, not more.
Categorized in -
Two Decades Later, Uptake of Less Invasive Valve Replacement for Heart Disease Remains Low Despite Billions in Social Value
The USC Schaeffer white paper illustrates procedure’s benefits for older Americans yet uptake remains low.
Categorized in -
Federal Government Should Advise on Drug Negotiations, Not Run Them
Schaeffer Center experts Karen Mulligan and Darius Lakdawalla argue that the Department of Health and Human Services should help advice drug price negotiations instead of running them.
Categorized in -
Study Finds More Than 9 Million Excess Life Years Lost During COVID Pandemic
Black and Hispanic persons have experienced a disproportionate number of life-years lost.
Categorized in -
Money for the Infrastructure Bill is Coming at the Expense of Medicare Part D
The $1 trillion infrastructure bill will leave a lot of chronically ill people by the side of the road.
Categorized in